Related references
Note: Only part of the references are listed.Interleukin-21: Basic biology and implications for cancer and autoimmunity
Rosanne Spolski et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype
Kerry A. Casey et al.
JOURNAL OF IMMUNOLOGY (2007)
Adoptive T cell therapy for cancer in the clinic
Carl H. June
JOURNAL OF CLINICAL INVESTIGATION (2007)
Cytokines and T-cell homeostasis
Onur Boyman et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
The molecular basis of IL-21-mediated proliferation
Rong Zeng et al.
BLOOD (2007)
Principles of adoptive T cell cancer therapy
Carl H. June
JOURNAL OF CLINICAL INVESTIGATION (2007)
Immunotherapy for renal cell cancer
James C. Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation
Bernd Jahrsdorfer et al.
BLOOD (2006)
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer
Michael H. Kershaw et al.
CLINICAL CANCER RESEARCH (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Both integrated and differential regulation of components of the IL-2/IL-2 receptor system
Hyoung Pyo Kim et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
IL-21 inhibits IFN-γ production in developing Th1 cells through the repression of eomesodermin expression
Akira Suto et al.
JOURNAL OF IMMUNOLOGY (2006)
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Thomas A. Waldmann
NATURE REVIEWS IMMUNOLOGY (2006)
Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells:: Importance for the therapeutic effectiveness of cell transfer immunotherapy
Jianping Huang et al.
JOURNAL OF IMMUNOLOGY (2006)
Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases
G Pantaleo et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Adoptive immunotherapy for cancer: building on success
L Gattinoni et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo
T Willinger et al.
JOURNAL OF IMMUNOLOGY (2006)
Programming CD8(+) T cells for effective immunotherapy
Christian S. Hinrichs et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells
R Ettinger et al.
JOURNAL OF IMMUNOLOGY (2005)
Host-reactive CD8+ memory stem cells in graft-versus-host disease
Y Zhang et al.
NATURE MEDICINE (2005)
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
AM Intlekofer et al.
NATURE IMMUNOLOGY (2005)
Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy
JH Zhou et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response
YQ Li et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells
NL Alves et al.
JOURNAL OF IMMUNOLOGY (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Understanding the generation and function of memory T cell subsets
A Lanzavecchia et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
L Gattinoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance
AW Duncan et al.
NATURE IMMUNOLOGY (2005)
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function
R Zeng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Interleukin-21: A modulator of lymphoid proliferation, apoptosis and differentiation
WJ Leonard et al.
NATURE REVIEWS IMMUNOLOGY (2005)
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cutting edge: Persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy
PF Robbins et al.
JOURNAL OF IMMUNOLOGY (2004)
Genetic modification of T lymphocytes for adoptive immunotherapy
C Rossig et al.
MOLECULAR THERAPY (2004)
Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of blimp-1 and bcl-61
K Ozaki et al.
JOURNAL OF IMMUNOLOGY (2004)
Lessons from the study of T-cell differentiation in persistent human virus infection
V Appay et al.
SEMINARS IN IMMUNOLOGY (2004)
Interleukin-21 inhibits dendritic cell activation and maturation
K Brandt et al.
BLOOD (2003)
Interleukin-21 inhibits dendritic cell-mediated t cell activation and induction of contact hypersensitivity in vivo
K Brandt et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Control of effector CD8+ T cell function by the transcription factor Eomesodermin
EL Pearce et al.
SCIENCE (2003)
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells
WW Overwijk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A role for Wnt signalling in self-renewal of haematopoietic stem cells
T Reya et al.
NATURE (2003)
The ABCs of granule-mediated cytotoxicity: New weapons in the arsenal
J Lieberman
NATURE REVIEWS IMMUNOLOGY (2003)
Analysis of γc-family cytokine target genes -: Identification of dual-specificity phosphatase 5 (DUSP5) as a regulator of mitogen-activated protein kinase activity in interleukin-2 signaling
PE Kovanen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A critical role for IL-21 in regulating immunoglobulin production
K Ozaki et al.
SCIENCE (2002)
Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon γ-producing Th1 cells
AL Wurster et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
IL-21 limits NK cell responses and promotes antigen-specific T cell activation: A mediator of the transition from innate to adaptive immunity
MT Kasaian et al.
IMMUNITY (2002)
Migratory properties of naive, effector, and memory CD8+ T cells
W Weninger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Progress in human tumour immunology and immunotherapy
SA Rosenberg
NATURE (2001)
Skewed maturation of memory HIV-specific CD8 T lymphocytes
P Champagne et al.
NATURE (2001)
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function
J Parrish-Novak et al.
NATURE (2000)
Cloning of a type I cytokine receptor most related to the IL-2 receptor β chain
K Ozaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
R Childs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The role of Stat5a and Stat5b in signaling by IL-2 family cytokines
JX Lin et al.
ONCOGENE (2000)
Share Paper
